LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- SSRIs and the Warning Signs
Jan-11-07 San Jose, CA Increasingly, new information and studies regarding SSRIs are warnings about the risks of birth defects if taken during pregnancy. It is now known that the use of any SSRI antidepressant in the first trimester of pregnancy is dangerous. One study resulted in a 40% increase in birth defects and more specifically a 60% increased risk in car... - Fired without Cause? Appeal!
Jan-9-07 Sacramento, CA Lou Ron's boss wanted to fire him but he couldn't think of a reason that would satisfy the California labor law, so he was fired for misconduct. Fortunately for Ron, his scheme backfired, but it isn't over yet. In November, 2005 Lou Ron pulled into a gas station with a co-worker, both wearing their white painting overalls. He was approach... - Business Booming for SSRI Makers
Jan-8-07 Washington, DC: The market for antidepressants is the largest segment of the Central Nervous System drug sector with global sales of $16.2 billion in 2005. Depression costs the US economy an estimated $44 billion a year and the World Health Organization predicts depression will be the leading cause of disability by 2020, according to a report by Research a... - Bayer excuse for hiding Trasylol Study Not Good Enough
Jan-7-07 Washington, DC: In October 2006, the German-based drug maker, Bayer AG, said it was a "mistake" to withhold a study from the FDA that showed the drug, Trasylol , can cause lethal side effects and that the company had suspended two employees involved in the fiasco. Critics say that's not good enough. An October 4, 2006 editorial, titled, "Bayer's Dup... - Novartis failed to Warn about Elidel Cancer Link
Dec-28-06 Washington, DC: Most lawsuits in which drug makers have tried to use preemption to dismiss failure-to-warn claims have been against companies accused of failing to warn about the risk of suicide associated with antidepressants known as selective serotonin inhibitors or SSRIs. However, a case in Pennsylvania against Novartis, involves a toddler who devel... - Spine Surgery performed much too Often
Dec-23-06 New Jersey: For senior citizens, the chances of receiving spine surgery, along with the serious complications that often follow, depends on where a patient lives, according to researchers from Dartmouth Medical School in the November 2006 medical journal Spine. For the study, the researchers analyzed data on lower back (lumbar) surgery among Medicare re... - What did Bayer know about Trasylol?
Dec-23-06 Washington, DC: In January, 2006, the FDA issued a Public Health Advisory for Trasylol , based on the serious health risks found in two studies, "A Propensity Score Case-Control Comparison of Aprotinin and Tranexamic Acid in High Transfusion Risk Cardiac Surgery," by Karkouti et al, in the Journal of Transfusion, and "The Risk Associated with Aprotinin in... - FDA Ignores Bayer Trasylol Fraud
Dec-21-06 Washington, DC: On December 15, 2006, the FDA said a new label for Trasylol will specify that it should only be used during coronary artery bypass graft surgery but the agency said nothing about what it plans to do about the fraudulent conduct of Bayer Pharmaceuticals in concealing a study that showed the increased risks associated with the drug. Righ... - Drug Makers Trolling for Infants and Toddlers
Dec-21-06 The motive behind Big Pharma's promotion of the off-label prescribing of psychotropic drugs is market expansion and unfortunately, it just so happens that children provide the richest harvest because most kids are covered by health insurance plans or Medicaid. The various recruitment schemes include trolling for customers among infants and toddlers betwee... - Court Allows Eli Lilly to Bury Zyprexa Documents
Dec-21-06 New York, NY Alaskan attorney, Jim Gottstein, says that after being served with a mandatory injunction, he has returned the internal Eli Lilly documents that he obtained in litigation and provided to the New York Times to the court. Information from the documents related to Lilly's antipsychotic drug, Zyprexa , was highlighted two days in a row in fr... - Doctor's Perks and Free Drug Samples Cost Patients Plenty
Dec-20-06 Washington, DC: In the debate over whether Big Pharma's perks lead doctors to prescribe high priced brand-name drugs over equally effective generics, the question to ask is whether an industry would direct 90% of a $20 billion marketing budget at doctors if it did not work. As lawmakers enact measures to limit the drug company's influence over the medic... - Defective Products In Your Body
Dec-18-06 Sacramento, CA In May 2000, Virginia was injured in a car accident and required a hip replacement. A sulzer hip was implanted in March but shortly afterward Sulzer Orthopedics recalled its Inter-Op acetabular shell for hip implants on December 8, 2000. Some of these implants had an unacceptable level of mineral oil-based lubricant on the product and it... - Flu Vaccines - Open Season
Dec-15-06 For all the frantic, unvaccinated citizens fearing the "upcoming" peak of flu season—rest assured, coming down with a flu infection is the least of your worries. Despite the governments statements urging individuals to vaccinate their children, the threat of an infantile influenza fatality is just about as serious as the dreaded hangnail. Noneth... - FDA requesting advice about Ketek
Dec-12-06 The Food and Drug Administration (FDA) is seeking outside advice in determining whether or not the antibiotic Ketek should stay on the market, according to an article in the New York Times. The advice will come from experts on anti-infective drugs who will sit at a public meeting to discuss Ketek. The meetings are scheduled to take place December 14 and... - Experts Says Warn About Stents - FDA Says No
Dec-11-06 Washington, DC: What to do about the problematic over-use of drug-eluting stents has become a problem in itself. A recall is out of the question, because 3 million people in the US already have the devices implanted in their chests, according to USA today. Drug-eluting stents (DES) are mesh tubes used in patients with heart disease to keep their arter... - Xbox 360: More unhappy customers and a lawsuit
Dec-10-06 Mount Clemens, MI: Bryan Thompson purchased his Xbox 360 in April, 2006. By November he was already sending it in for repairs because "the red ring of death" had appeared on the front of his console, meaning his console was unusable. Bryan had heard that the October update was causing problems for some people, but says that his problems did not start... - Weighing Benefits of SSRIs Against Suicide Risk
Dec-8-06 Washington, DC: Before the FDA's Psychopharmacologic Drugs Advisory Committee begins the discussion at the December 13, 2006, public hearing on the suicide risks associated with selective serotonin inhibitor antidepressants , it should get honest with the audience and openly admit that the SSRIs do not even work. Medical professionals maintain that in... - Mental Illness Epidemic Hits US
Dec-7-06 Washington, DC: In the run-up to the December 13, 2006, meeting of the FDA's Psychopharmacologic Drugs Advisory Committee, to review the suicidality data from adult SSRI studies, a host of newly identified disorders have been popping up in the media, all treatable with SSRIs. The committee is expected to vote on whether the association between the sel... - Ketek Fraud Investigation Derails Confirmation of New FDA Commissioner
Dec-6-06 Washington, DC: When the Democrats won control of Congress, Senator Charles Grassley may have lost the chairmanship of the Senate Finance Committee, but the current acting FDA commissioner had better not get too settled in because the Senator is apparently not ready to throw in the towel in the on-going battle with him. In a recent press release accompa... - Stockbroker Arbitration claiming Improper Trading Strategies
Dec-5-06 Coral Springs, FL: A securities law firm announced on November 15, 2006 that it has filed multiple stockbroker arbitration claims on behalf of former Axiom customers. The arbitration suit claims improper trading strategies with regards to Vistula (OTCBB:VSTL), iCurie, now known as Celsia Technologies, Inc (OTCBB:CSAT) and Xenomicx (OTCBB:XNOM). It al...